Skip to content

Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome

Active, not recruitingNot applicableNCT04734847
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a common, chronic, and debilitating condition in women. Preliminary evidence suggests that IC/BPS pain can be reduced applying non-invasive repetitive transcranial magnetic stimulation (rTMS) to areas of the brain that regulate pelvic floor muscle activity. However, prior studies have examined rTMS in a very limited sample and have not examined changes in brain or pelvic floor muscle activity to determine the mechanism of rTMS for IC/BPS. This study is designed to directly address these limitations.

Study details

Official title
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome: Reducing Pain by Improving Brain and Muscle Activity
Interventions
Sponsor
University of Southern California
Start date
2021-06-01
Primary completion
2026-05-20
Sex
Female
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Be at least 18 years old. 2. Be female. 3. Have a diagnosis of IC/BPS by the referring physician, with urologic symptoms present a majority of the time during the most recent 3 months 4. Screen within standard limits for pelvic pain Exclusion Criteria: 1. Symptomatic urethral stricture 2. On-going neurological conditions affecting the bladder or bowel 3. Active auto-immune or infectious disorders 4. History of cystitis caused by tuberculosis or radiation or chemotherapies 5. History of non-dermatologic cancer 6. Current major psychiatric disorders 7. Severe cardiac, pulmonary, renal, or hepatic disease 8. Conditions or the use of medical devices that are contraindications for either fMRI or rTMS procedures, including pregnancy, seizure disorders, or chronic headaches

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04734847